FDA Crime Head To Depart Amid Misconduct Claims

Law360, New York (November 24, 2010, 1:53 PM EST) -- Terry Vermillion on Tuesday reportedly told U.S. Food and Drug Administration staff that he would step down as head of the agency’s Office of Criminal Investigations, where he served for 18 years, about two months after a whistleblower accused him of unethical conduct.

 

Further details about Vermillion’s resignation weren’t immediately available. FDA representatives didn’t immediately respond to requests for comment Wednesday, and a call to the OCI wasn’t immediately returned.

 

"We appreciate Terry's years of public service and wish him well in retirement," FDA...
To view the full article, register now.